EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Retinal detachment

Jonathan B Lin, Raja Narayanan, Elise Philippakis, Yoshihiro Yonekawa, Rajendra S Apte

Nature Reviews Disease Primers · 14.03.2024 · 10 (1)

DOI: 10.1038/s41572-024-00501-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nature Reviews Disease Primers, online erschienen am 14.03.2024. Verfasst von Jonathan B Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Retinal Detachment. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 133 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal detachment (RD) occurs when the neurosensory retina, the neurovascular tissue responsible for phototransduction, is separated from the underlying retinal pigment epithelium (RPE). Given the importance of the RPE for optimal retinal function, RD invariably leads to decreased vision. There are three main types of RD: rhegmatogenous, tractional and exudative (also termed serous) RD. In rhegmatogenous RD, one or more retinal breaks enable vitreous fluid to enter the subretinal space and separate the neurosensory retina from the RPE. In tractional RD, preretinal, intraretinal or subretinal membranes contract and exert tangential forces and elevate the retina from the underlying RPE. Finally, in exudative RD, an underlying inflammatory condition, vascular abnormality or the presence of a tumour causes exudative fluid to accumulate in the subretinal space, exceeding the osmotic pump function of the RPE. The surgical management of RD usually involves pars plana vitrectomy, scleral buckling or pneumatic retinopexy. The approach taken often depends on patient characteristics as well as on practitioner experience and clinical judgement. Advances in surgical technology and continued innovation have improved outcomes for many patients. However, even if retinal re-attachment is achieved, some patients still experience decreased vision or other visual symptoms, such as metamorphopsia, that diminish their quality of life. Continued research in the areas of neuroprotection and retinal biology as well as continued surgical innovation are necessary to enhance therapeutic options and outcomes for these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal DetachmentHumansQuality of LifeScleral BucklingVitrectomyTreatment Outcome

Autor:innen und Institutionen

  • Massachusetts Eye and Ear and Harvard Medical School, Boston, MA, USA.
  • Anant Bajaj Retina Institute, LV Prasad Eye Institute, Hyderabad, India.
  • Université de Paris, Ophthalmology Department, AP-HP, Hôpital Lariboisière, Paris, France.
  • Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.
  • John F. Hardesty, MD, Department of Ophthalmology and Visual Sciences, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. apte@wustl.edu.
  • Department of Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA. apte@wustl.edu.

Zitieren

APA

Lin, J. B., Narayanan, R., Philippakis, E., Yonekawa, Y., & Apte, R. S. (2024). Retinal detachment. Nature Reviews Disease Primers, 10(1). https://doi.org/10.1038/s41572-024-00501-5

Vancouver

Lin JB, Narayanan R, Philippakis E, Yonekawa Y, Apte RS. Retinal detachment. Nature Reviews Disease Primers. 2024;10(1). doi:10.1038/s41572-024-00501-5

BibTeX
@article{Lin2024,
  author = {Lin, Jonathan B and Narayanan, Raja and Philippakis, Elise and Yonekawa, Yoshihiro and Apte, Rajendra S},
  title = {Retinal detachment},
  journal = {Nature Reviews Disease Primers},
  year = {2024},
  volume = {10},
  number = {1},
  doi = {10.1038/s41572-024-00501-5}
}
Kostenlos starten →